Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.06.471455Source: DataRank Database

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (26)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Cong Zeng ORCID,Claire Carlin ORCID,Gerard Lozanski ORCID,Linda J. Saif ORCID,Eugene M. Oltz ORCID

Live enrichment

PubMed:34909777 OpenAlex:https://openalex.org/W4200553651

National Institutes of Health

Grant: 5R01HD095881-03

The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections

National Institutes of Health

Grant: 5R01HL127442-04

Ectonucleotidases in ischemic heart disease

National Institutes of Health

Grant: 3U54CA260582-02S3

Center for serological testing to improve outcomes from pandemic COVID-19 (STOP-COVID)

National Institutes of Health

Grant: 5R01AI150473-04

TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef

NIAID NIH HHS

Grant: R01 AI150473

NICHD NIH HHS

Grant: R01 HD095881

NHLBI NIH HHS

Grant: R01 HL127442

NCI NIH HHS

Grant: U54 CA260582

greenLicense: cc-by-nc

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/12/07/2021.12.06.471455.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.12.06.471455

repositoryhttps://doi.org/10.1101/2021.12.06.471455

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34909777

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral Infections and Immunology Research0301 basic medicine03 medical and health sciences

Keywords

Neutralizing antibodyVaccinationTiterVirologyMedicineAntibodyBooster doseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyAntibody titerAntibody responseCoronavirus disease 2019 (COVID-19)ImmunityMessenger RNABiologyImmune systemGeneInfectious disease (medical specialty)Internal medicineDiseaseArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection

FAIR Checklist

Authors (8)

Funding (8 grants)

Open Access

Topics

Annotations (Europe PMC)